Subscribe

KraneShares MSCI All China Health Care Index ETF (KURE)

USD16.86 -0.13 (-0.77%)
AMEX USD US Equity
NAV USD 16.93 -0.41% vs NAV as of 2026-07-13
AUM USD 79.56M
TER 0.79%
Yield (TTM) 4.24%
Distribution Distributing · Annual
52-week range 14.52 – 21.84
Holdings 49
Issuer KraneShares

About this ETF

This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.

ISIN US5007678353
Issuer KraneShares
Domicile US
Inception 2018-01-31
Asset class Equity

Price

Top 10 holdings

INNOVENT BIOLOGICS INC 1801.HK 9.20%
BEONE MEDICINES LTD-H 6160.HK 8.82%
WUXI BIOLOGICS CAYMAN INC 2269.HK 7.63%
WUXI APPTEC CO LTD-A 603259.SS 5.30%
JIANGSU HENGRUI PHARMACEUT-A 600276.SS 4.55%
SHENZHEN MINDRAY BIO-MEDIC-A 300760.SZ 4.13%
CSPC PHARMACEUTICAL GROUP LT 1093.HK 3.96%
AKESO INC 9926.HK 3.84%
SINO BIOPHARMACEUTICAL 1177.HK 3.69%
WUXI APPTEC CO LTD-H 2359.HK 3.14%
See full holdings →